Evidence map›Paper›PMID 27010837›Full record

ArticlePloS one2016

UmuDAb: An Error-Prone Polymerase Accessory Homolog Whose N-Terminal Domain Is Required for Repression of DNA Damage Inducible Gene Expression in Acinetobacter baylyi.

Travis A Witkowski, Alison N Grice, DeAnna B Stinnett, Whitney K Wells, Megan A Peterson, Janelle M Hare

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Repression ofJournal of bacteriology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Homodimerization and heterodimerization requirements ofCanadian journal of microbiology · 2021
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Travis A WitkowskiDepartment of Biology and Chemistry, Morehead State University, Morehead, KY, United States of America.
Alison N GriceDepartment of Biology and Chemistry, Morehead State University, Morehead, KY, United States of America.
DeAnna B StinnettDepartment of Biology and Chemistry, Morehead State University, Morehead, KY, United States of America.
Whitney K WellsDepartment of Biology and Chemistry, Morehead State University, Morehead, KY, United States of America.
Megan A PetersonDepartment of Biology and Chemistry, Morehead State University, Morehead, KY, United States of America.
Janelle M HareDepartment of Biology and Chemistry, Morehead State University, Morehead, KY, United States of America.
Morehead State University · US

Funding

WKU Lead Faculty AwardP20GM103436 · NIGMS · UNIVERSITY OF LOUISVILLE · PI ERIC C ROUCHKA · 2012 to 2026
$60.1M
ZEBRAFISH VISUAL FUNCTION RECOVERY FOLLOWING OPTIC NERVE DAMAGEP20RR016481 · NCRR · UNIVERSITY OF LOUISVILLE · PI BARTON, HAZEL A · 2001 to 2011
$34.8M
Mechanisms of Action of UmuD in Regulating DNA Damage-Induced Genes in a umuC- Deficient mutantR15GM085722 · NIGMS · MOREHEAD STATE UNIVERSITY · PI Janelle M Hare · 2009 to 2026
$1.8M
NCRR NIH HHS P20 RR016481NIGMS NIH HHS P20 GM103436NIGMS NIH HHS P20GM103436NIGMS NIH HHS R15 GM085722NIGMS NIH HHS R15GM085722
6 · The paper itself

Abstract

In many bacteria, the DNA damage response induces genes (SOS genes) that were repressed by LexA. LexA represses transcription by binding to SOS promoters via a helix-turn-helix motif in its N-terminal domain (NTD). Upon DNA damage, LexA cleaves itself and allows induction of transcription. In Acinetobacter baumannii and Acinetobacter baylyi, multiple genes are induced by DNA damage, and although the Acinetobacter genus lacks LexA, a homolog of the error-prone polymerase subunit UmuD, called UmuDAb, regulates some DNA damage-induced genes. The mechanism of UmuDAb regulation has not been determined. We constructed UmuDAb mutant strains of A. baylyi to test whether UmuDAb mediates gene regulation through LexA-like repressor actions consisting of relief of repression through self-cleavage after DNA damage. Real-time quantitative PCR experiments in both a null umuDAb mutant and an NTD mutant showed that the DNA damage-inducible, UmuDAb-regulated gene ddrR was highly expressed even in the absence of DNA damage. Protein modeling identified a potential LexA-like helix-turn-helix structure in the UmuDAb NTD, which when disrupted, also relieved ddrR and umuDAb repression under non-inducing conditions. Mutations in a putative SOS box in the shared umuDAb-ddrR promoter region similarly relieved these genes' repression under non-inducing conditions. Conversely, cells possessing a cleavage-deficient UmuDAb were unable to induce gene expression after MMC-mediated DNA damage. This evidence of a UmuDAb repressor mechanism was contrasted with the failure of umuDAb to complement an Escherichia coli umuD mutant for UmuD error-prone DNA replication activity. Similarly, A. baumannii null umuDAb mutant cells did not have a reduced UmuD'2UmuC-mediated mutation rate after DNA damage, suggesting that although this UmuDAb protein may have evolved from a umuDC operon in this genus, it now performs a LexA-like repressor function for a sub-set of DNA damage-induced genes.

Indexed as

SOS Response, GeneticsAcinetobacterBacterial ProteinsDNA DamageDNA-Directed DNA PolymeraseDNA ReplicationEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialLexA Repressor ProteinRepressor ProteinsSerine EndopeptidasesBacterial ProteinsDNA-Directed DNA PolymeraseEscherichia coli ProteinsLexA Repressor ProteinRepressor ProteinsSerine EndopeptidasesUmuD protein, E coli

Identifiers

PMID27010837
PMCPMC4807011
OpenAlexW2305347937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.